Zepbound (Tirzeparide) is injectable glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP) agonist approved by FDA for use in obese (BMI≥30) or overweight adults (BMI≥27) with at least one weight-related condition who struggle to reduce body weight by changing diet and regular exercise.
However, despite the effectiveness proven by clinical studies due to the high cost, side effects and route of administration it might not be suitable for everyone.
In this article we will discuss available alternatives: over-the-counter options and compounded Tirzepatide.